Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Directors Dealing

4 Nov 2014 14:10

HAYDALE GRAPHENE INDUSTRIES PLC - Directors Dealing

HAYDALE GRAPHENE INDUSTRIES PLC - Directors Dealing

PR Newswire

London, November 4

Haydale Graphene Industries plc (the "Company") Director's Dealing The Company was informed on 3 November 2014 that on that day Dr ChristopherSpacie, Technical Director of the Company, purchased 8,312 ordinary shares of2p each in the Company ("Ordinary Shares") at a price of 60p per OrdinaryShare. Following this transaction, Dr Christopher Spacie is now interested in35,463 Ordinary Shares, representing 0.32% of the total voting rights of theCompany of 11,247,823 Ordinary Shares. For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 020 7148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Broker)David Foreman 020 7894 7684Paul Jewell 020 7894 7644 Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687
Date   Source Headline
7th Aug 201810:24 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Aug 20187:00 amRNSWorld's First Graphene Skinned Plane
18th Jul 20187:00 amRNSNPL & NGI launch graphene characterisation service
13th Jul 20182:05 pmRNSSecond Price Monitoring Extn
13th Jul 20182:00 pmRNSPrice Monitoring Extension
25th Jun 20187:00 amRNSPartnership with GEIC
22nd Jun 20184:20 pmRNSNotification of Major Holdings
20th Jun 20182:52 pmRNSDirector Dealing
19th Jun 20187:00 amRNSStrong Commercial Progress
18th Jun 20187:00 amRNSNotification of Major Holdings
13th Jun 20189:05 amRNSSecond Price Monitoring Extn
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing
19th Apr 20177:00 amRNSPDMR Dealing
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.